Hypertension:诊室治疗的目标血压可能与家庭血压阈值相同

2018-11-21 佚名 嘉音

10月29日,在线发表于《Hypertension》杂志上的一项研究表明,建议将130/80mmHg的临床血压阈值作为诊室治疗的目标血压,也可以作为大多数高血压患者治疗的家庭血压目标。

10月29日,在线发表于《Hypertension》杂志上的一项研究表明,建议将130/80mmHg的临床血压阈值作为诊室治疗的目标血压,也可以作为大多数高血压患者治疗的家庭血压目标。

2017美国AHA/ACC颁布的高血压管理指南建议将血压大于130/80mmHg作为高血压诊断阈值。该指南更强调对诊室外的血压水平的监测。目前在美国,大约只有30%~45%的高血压患者规律监测他们的血压,然而这个比例在中国更低。通过该指南,临床医生将进一步鼓励患者多监测家庭血压水平,并提供一个更准确的血压状态。但是指南中关于认为诊室血压130/80mmHg的水平等同于家庭血压水平和白天动态血压水平的证据是基于非美国人群队列研究,因此不能确定这个水平的诊室血压与家庭血压水平是否真正反应了美国人群的事实。

美国达拉斯德克萨斯大学西南医学中心的Wanpen Vongpatanasin 博士和同事对达拉斯心脏研究(n=5768)和北卡罗来纳州白隐形高血压研究(n=420)的受试者的数据进行了分析。这两项队列研究均包括了家庭血压和诊室血压水平。对达拉斯队列中未接受高血压药物的受试者数据的回归分析发现,与诊室血压130/80mmHg对应的家庭血压阈值在非裔美国人中为129/80mmHg,白人为130/80mmHg,西班牙裔人为126/78mmHg。北卡罗来纳州的队列中得出的结果与该队列是相似的。然后,研究人员对结局事件分析来确定什么水平的家庭血压与全因死亡率或血管事件的11年风险相关。在该分析中,相比于未经治疗的受试者的种族/族裔群体,在诊室收缩压为130mmHg时观察到的结局事件风险对应的家庭血压在非裔美国人,白人和西班牙裔人群中分别为130mmHg,129mmHg和131mmHg。

该研究的主要作者Vongpatanasin博士写道:“因为对结局事件风险的影响被认为是黄金标准,所以我们的研究数据为新的ACC/AHA指南提出的家庭血压阈值提供了支持。因为诊室血压阈值为130/80mmHg也是由ACC/AHA指南提出作为诊室治疗的目标血压,我们的研究结果建议,130/80mmHg的家庭血压可用作大多数高血压患者的家庭血压治疗目标。”

但同时,在针对这项研究结果的一篇社论中,匹兹堡大学医学中心高血压诊所的Matthew Muldoon博士提出了一些担忧。他说,该研究中分析的较大的达拉斯队列中的诊室血压读数是在一次研究访问时获得的,然而目前诊断高血压标准是至少需要两次单独访问期间进测量的血压水平。他说,家庭血压的测量可能并不像通常那样普遍。因此,他们测量的家庭血压水平的合理可靠程度并不符合今天的标准。”Muldoon还指出,另一个主要问题是研究样本的组成。在达拉斯心脏研究中未经治疗的队列的平均年龄仅为37岁,平均收缩压为124mmHg,提示这是一个健康的正常血压组。他认为,一项更好的研究将包括大多数40岁以上血压升高的人。此外,最重要的是,他认为这项研究的设计不足以解释高血压风险人群中诊室和家庭血压之间的相关性。进行一项随机试验可能会更好的给这个问题一个可靠的答案。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1727750, encodeId=20981e277506e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Oct 14 02:44:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038989, encodeId=d99f203898924, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu May 02 20:44:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353710, encodeId=753d353e1095, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:08:27 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353709, encodeId=e366353e092c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:07:42 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501333, encodeId=fb2b1501333c9, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553606, encodeId=b5b91553606f4, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=)]
    2019-10-14 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1727750, encodeId=20981e277506e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Oct 14 02:44:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038989, encodeId=d99f203898924, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu May 02 20:44:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353710, encodeId=753d353e1095, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:08:27 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353709, encodeId=e366353e092c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:07:42 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501333, encodeId=fb2b1501333c9, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553606, encodeId=b5b91553606f4, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1727750, encodeId=20981e277506e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Oct 14 02:44:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038989, encodeId=d99f203898924, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu May 02 20:44:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353710, encodeId=753d353e1095, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:08:27 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353709, encodeId=e366353e092c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:07:42 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501333, encodeId=fb2b1501333c9, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553606, encodeId=b5b91553606f4, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=)]
    2018-11-26 12282355m97暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1727750, encodeId=20981e277506e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Oct 14 02:44:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038989, encodeId=d99f203898924, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu May 02 20:44:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353710, encodeId=753d353e1095, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:08:27 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353709, encodeId=e366353e092c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:07:42 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501333, encodeId=fb2b1501333c9, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553606, encodeId=b5b91553606f4, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=)]
    2018-11-26 12282355m97暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1727750, encodeId=20981e277506e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Oct 14 02:44:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038989, encodeId=d99f203898924, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu May 02 20:44:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353710, encodeId=753d353e1095, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:08:27 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353709, encodeId=e366353e092c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:07:42 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501333, encodeId=fb2b1501333c9, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553606, encodeId=b5b91553606f4, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1727750, encodeId=20981e277506e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Oct 14 02:44:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038989, encodeId=d99f203898924, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Thu May 02 20:44:00 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353710, encodeId=753d353e1095, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:08:27 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353709, encodeId=e366353e092c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0af42337291, createdName=12282355m97暂无昵称, createdTime=Mon Nov 26 15:07:42 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501333, encodeId=fb2b1501333c9, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553606, encodeId=b5b91553606f4, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Nov 23 13:44:00 CST 2018, time=2018-11-23, status=1, ipAttribution=)]
    2018-11-23 qjddjq

相关资讯

ASH 2014:夜间血压——预测患者的临床预后指标

"尽管24小时动态血压监测(ABPM)测量日间和夜间血压已开展多年,但目前仍不清楚哪些指标能预测患者的临床预后。"——George Roush博士美国时间5月16日至20日,第29界美国高血压学会(ASH)科学年会于纽约市举行。会议期间公布的一项大型荟萃分析显示,诊室血压与心血管疾病预后(包括卒中)之间无相关性,相反,夜间血压与不良临床预后风险相关,夜间收缩压每升高10 mmHg,心血管不良预后风

Circulation:诊室血压<130/80 mm Hg患者的隐匿性高血压发病率

最新指南提出,将高血压定义为诊室血压测量收缩压≥130 mm Hg或舒张压≥80 mm Hg新值,以及药物治疗目标值<130/80 mm Hg。24 h动态血压监测(ABPM)和家庭血压自测通常用于检测“白大衣”高血压。相反,隐匿性高血压(MH)是指正常诊室血压和家中自测或24 h ABPM正常的血压。近日,Circulation杂志发表的一项基于24 h ABPM诊室血压<130 / <80 m

JAMA Intern Med:装置引导呼吸未能显著降低诊室血压

荷兰一项荟萃分析表明,与音乐治疗和假装置相比,装置引导呼吸(DGB)未能显著降低诊室血压。相关论文9月15日在线发表于《美国医学会杂志·内科学》(JAMA Intern Med)。 研究者检索了Medline、EMBASE、clinicaltrials.gov和Cochrane数据库,并纳入了持续时间最少4周、采用双盲或单盲设计、具有活性对照组的DGB试验。主要转归指标为诊室血压。 结果显示,

NEJM:动态血压较诊室血压更能预测死亡

与诊室或家庭单次偶测血压相比,动态血压监测能获得更全面的血压信息,并具有识别特殊类型高血压(如白大衣高血压、隐匿性高血压和夜间高血压)的优势从而减少漏诊误诊。

J Hypertens:抗高血压治疗对诊室和动态血压的不同影响

由此可见,该荟萃分析证实诊室血压总体治疗诱导降低程度明显大于24小时血压,但它也表明这两种测量方法之间的定量关系因人口统计学指标、临床和治疗条件以及与安慰剂校正有关。